-
Grazoprevir is a drug
approved for the
treatment of
hepatitis C. It was
developed by
Merck and
completed Phase III trials, used in
combination with the...
- Elbasvir/
grazoprevir, sold
under the
brand name Zepatier, is a fixed-dose
combination for the
treatment of
hepatitis C,
containing elbasvir (an inhibitor...
- RNA
polymerase inhibitor)
Dasabuvir (NS5B RNA
polymerase inhibitor)
Grazoprevir (NS3/4A
protease inhibitor)
Paritaprevir (NS3/4A
protease inhibitor)...
- w****s of elbasvir/
grazoprevir, ledipasvir/sofosbuvir, or sofosbuvir/velpatasvir. An
alternative treatment regimen of elbasvir/
grazoprevir with weight-based...
-
Phase III trials, used in
combination with the NS3/4A
protease inhibitor grazoprevir under the
trade name Zepatier,
either with or
without ribavirin. Elbasvir...
- NS3/4A
protease inhibitors—class stem –previr: 26
Asunaprevir Boceprevir Grazoprevir Glecaprevir Paritaprevir Simeprevir Telaprevir 3-chymotrypsin-like protease...
-
Daclatasvir J05AP08
Sofosbuvir J05AP09
Dasabuvir J05AP10
Elbasvir J05AP11
Grazoprevir J05AP12
Coblopasvir J05AP13
Ravidasvir J05AP51
Sofosbuvir and ledipasvir...
-
development of
antivirals for
Hepatitis C
Virus (HCV)
including Elbasvir and
Grazoprevir. She
currently serves as Vice
President for
Infectious Diseases Discovery...
-
Vosevi (sofosbuvir, velpatasvir, and voxilaprevir)
Zepatier (elbasvir and
grazoprevir)
Mavyret (glecaprevir and pibrentasvir) The
United States Food and Drug...
- Drug
Manufacturer Indication Elbasvir/
grazoprevir Merck Sharp &
Dohme Hepatitis C
Palbociclib Pfizer HR-positive, HER2-negative
breast cancer Crizotinib...
